What does Zentalis Pharmaceuticals, Inc. do?
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor…
What is Zentalis Pharmaceuticals, Inc.'s P/E and P/B ratio?
Zentalis Pharmaceuticals, Inc. has a P/E ratio of -1.2 and a P/B ratio of 1.65.
What is Zentalis Pharmaceuticals, Inc.'s debt-to-equity ratio?
Zentalis Pharmaceuticals, Inc. has a debt-to-equity ratio of 0.26.
How much does Zentalis Pharmaceuticals, Inc. owe compared with what it owns?
Zentalis Pharmaceuticals, Inc. owes $0.33 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Zentalis Pharmaceuticals, Inc.'s Positivity rank?
Zentalis Pharmaceuticals, Inc. is ranked #1,976 of 6,774 companies globally and #527 of 4,000 in United States on PositoAI, with a Positivity Score of 22,054.
Does Zentalis Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Zentalis Pharmaceuticals, Inc..
Where can I read the latest news about Zentalis Pharmaceuticals, Inc.?
Recent headlines about Zentalis Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Zentalis Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Zentalis Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.